Accessibility Menu
 
Oncology Pharma logo

Oncology Pharma

(OTC) ONPH

Current Price$0.06
Market Cap$1.65M
Since IPO (1992)-100%
5 Year-100%
1 Year+60,100%
1 Month-40%

Oncology Pharma Financials at a Glance

Market Cap

$1.65M

Revenue (TTM)

$0.00

Net Income (TTM)

$5.60M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-1198.67 (Low)

Price

$0.06

Volume

19,747

Open

$0.06

Previous Close

$0.06

Daily Range

$0.06 - $0.08

52-Week Range

$0.06 - $0.36

ONPH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oncology Pharma

Industry

Biotechnology

CEO

George Malesek

Headquarters

San Francisco, CA 94104, US

ONPH Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-0%

Return on Assets

-0%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.65M

Shares Outstanding

27.39M

Volume

19.75K

Avg. Volume

55.68K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$5.82K

EBITDA

$5.82K

Operating Cash Flow

$368.61K

Capital Expenditure

$0.00

Free Cash Flow

$368.61K

Cash & ST Invst.

$3.96K

Total Debt

$662.08K

Oncology Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.65M

N/A

Market Cap/Employee

$1.65M

N/A

Employees

1

N/A

Net Income

$820.00

+99.0%

EBITDA

$820.00

+99.0%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$777.22K

-368.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$777.62K

+362.9%

Return on Assets

-0.27%

N/A

Return on Invested Capital

-0.47%

N/A

Free Cash Flow

$1.98K

-98.4%

Operating Cash Flow

$1.98K

-98.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AMPEAmpio Pharmaceuticals, Inc.
$0.18+0.00%
WUHNWuhan General Group (China), Inc.
$0.00+0.00%
ARNIArno Therapeutics, Inc.
$0.00+0.00%
BTTXBetter Therapeutics, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$15.47+0.09%
AALAmerican Airlines Group
$13.85+0.02%
NIONio
$5.20-0.07%
INTCIntel
$119.84+0.01%

Questions About ONPH

What is the current price of Oncology Pharma?

Oncology Pharma is trading at $0.06 per share.

What is the 52-week range for Oncology Pharma?

Over the past 52 weeks, Oncology Pharma has traded between $0.06 and $0.36.

How much debt does Oncology Pharma have?

As of the most recent reporting period, Oncology Pharma reported total debt of N/A.

How much cash does Oncology Pharma have on hand?

Oncology Pharma reported $42,005 in cash and cash equivalents in its most recent financial results.

What is Oncology Pharma’s dividend yield?

Oncology Pharma does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.